SCHEMBL23394686

SCHEMBL23394686

CN(C)/N=N/c1[nH]cnc1C(=O)NC(C)(C)C

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.43
LMNA P02545 2/20 0.43
TSHR P16473 2/20 0.43
ALDH1A1 P00352 2/20 0.43
PAX8 Q06710 1/20 0.43
MMP9 P14780 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
MAPT P10636 2/20 0.38
TDP1 Q9NUW8 2/20 0.38
PKM P14618 1/20 0.38
L3MBTL1 Q9Y468 2/20 0.33
SYK P43405 3/20 0.31
DYRK1A Q13627 1/20 0.31
GLA P06280 1/20 0.31
GAA P10253 1/20 0.31
HPGD P15428 1/20 0.31
MAPK1 P28482 1/20 0.31
POLB P06746 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dacarbazine SCHEMBL1586950 0.79 PAX8 (0.59) KDM4ELMNATSHRALDH1A1PAX8
Dacarbazine SCHEMBL12591753 0.79 PAX8 (0.59) KDM4ELMNATSHRALDH1A1PAX8
Dacarbazine SCHEMBL5560 0.79 PAX8 (0.59) KDM4ELMNATSHRALDH1A1PAX8
Dacarbazine SCHEMBL6372 0.79 PAX8 (0.59) KDM4ELMNATSHRALDH1A1PAX8
Dacarbazine SCHEMBL28074490 0.78 PAX8 (0.57) KDM4ELMNATSHRALDH1A1PAX8
Dacarbazine SCHEMBL28090781 0.78 PAX8 (0.57) KDM4ELMNATSHRALDH1A1PAX8
Dacarbazine SCHEMBL28074492 0.78 PAX8 (0.57) KDM4ELMNATSHRALDH1A1PAX8
Dacarbazine SCHEMBL3957404 0.78 PAX8 (0.57) KDM4ELMNATSHRALDH1A1PAX8
Dacarbazine SCHEMBL28090782 0.78 PAX8 (0.57) KDM4ELMNATSHRALDH1A1PAX8
Dacarbazine SCHEMBL28242658 0.78 PAX8 (0.57) KDM4ELMNATSHRALDH1A1PAX8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11014953-B2 Trigger-activatable metabolic sugar precursors for cancer-selective labeling and targeting THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2021-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11014953-B2 Trigger-activatable metabolic sugar precursors for cancer-selective labeling and targeting GPI, SLC2A1, SLC2A4 KDM4E 1494/4885LMNA 3922/4885TSHR 1316/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.